0.022406
0.000000
0.000000
0.000000
0.022406
0.000000
0.000000
0.000000
0.007433
0.00000
0.00000
0.00000
Hohenester, E.
Sasaki, T.
Timpl, R.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
8
90.00
90.00
90.00
44.630
44.630
134.540
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
H2 O
18.015
WATER
non-polymer
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C8 H15 N O6
221.208
2-acetamido-2-deoxy-beta-D-glucopyranose
D-saccharide, beta linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Nat.Struct.Biol.
NSBIEW
2024
1072-8368
6
228
232
10.1038/6669
10074941
Crystal structure of a scavenger receptor cysteine-rich domain sheds light on an ancient superfamily.
1999
UK
Embo J.
EMJODG
0897
0261-4189
17
1606
Mac-2 Binding Protein is a Cell-Adhesive Protein of the Extracellular Matrix which Self-Assembles Into Ring-Like Structures and Binds Beta1 Integrins, Collagens and Fibronectin
1998
NE
Trends Biochem.Sci.
TBSCDB
0946
0968-0004
19
5
The Srcr Superfamily: A Family Reminiscent of the Ig Superfamily
1994
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
293
1
IMAGE PLATE
1998-07-07
MARRESEARCH
M
x-ray
1
1.5418
1.0
1.5418
ROTATING ANODE
ELLIOTT GX-21
12705.093
MAC-2 BINDING PROTEIN
SCAVENGER RECEPTOR CYSTEINE-RICH (SRCR) DOMAIN
N-TERMINAL APLA
1
man
polymer
221.208
2-acetamido-2-deoxy-beta-D-glucopyranose
1
man
non-polymer
18.015
water
57
nat
water
TUMOR-ASSOCIATED ANTIGEN 90K
no
no
APLAVNDGDMRLADGGATNQGRVEIFYRGQWGTVCDNLWDLTDASVVCRALGFENATQALGRAAFGQGSGPIMLDEVQCT
GTEASLADCKSLGWLKSNCRHERDAGVVCTNETRSTHTL
APLAVNDGDMRLADGGATNQGRVEIFYRGQWGTVCDNLWDLTDASVVCRALGFENATQALGRAAFGQGSGPIMLDEVQCT
GTEASLADCKSLGWLKSNCRHERDAGVVCTNETRSTHTL
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
human
Homo
sample
293-EBNA
9606
KIDNEY
Homo sapiens
293-EBNA
9606
Homo sapiens
PCEP-PU
1
2.6
50
TWO DERIVATIVES (SMCL3 AND UO2SO4) WERE USED AT 3.0 A
6.0
pH 6.0
chem_comp
entity
pdbx_chem_comp_identifier
pdbx_entity_nonpoly
pdbx_unobs_or_zero_occ_atoms
struct_conn
struct_site
struct_site_gen
repository
Initial release
Carbohydrate remediation
repository
Remediation
Version format compliance
Non-polymer description
Version format compliance
Advisory
Data collection
Derived calculations
Structure summary
1
0
1999-05-18
1
1
2008-03-24
1
2
2011-07-13
1
3
2020-07-29
_chem_comp.name
_chem_comp.type
_entity.pdbx_description
_pdbx_entity_nonpoly.name
_struct_conn.pdbx_leaving_atom_flag
_struct_conn.pdbx_role
_struct_conn.ptnr1_auth_comp_id
_struct_conn.ptnr1_auth_seq_id
_struct_conn.ptnr1_label_asym_id
_struct_conn.ptnr1_label_atom_id
_struct_conn.ptnr1_label_comp_id
_struct_conn.ptnr1_label_seq_id
_struct_conn.ptnr2_auth_comp_id
_struct_conn.ptnr2_auth_seq_id
_struct_conn.ptnr2_label_asym_id
_struct_conn.ptnr2_label_atom_id
_struct_conn.ptnr2_label_comp_id
_struct_conn.ptnr2_label_seq_id
DGlcpNAcb
N-acetyl-b-D-glucopyranosamine
b-D-GlcpNAc
GlcNAc
Y
BNL
1998-10-23
REL
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose
HOH
water
NAG
201
2
NAG
NAG
201
A
HOH
301
3
HOH
HOH
301
A
HOH
302
3
HOH
HOH
302
A
HOH
303
3
HOH
HOH
303
A
HOH
304
3
HOH
HOH
304
A
HOH
305
3
HOH
HOH
305
A
HOH
306
3
HOH
HOH
306
A
HOH
307
3
HOH
HOH
307
A
HOH
308
3
HOH
HOH
308
A
HOH
309
3
HOH
HOH
309
A
HOH
310
3
HOH
HOH
310
A
HOH
311
3
HOH
HOH
311
A
HOH
312
3
HOH
HOH
312
A
HOH
313
3
HOH
HOH
313
A
HOH
314
3
HOH
HOH
314
A
HOH
315
3
HOH
HOH
315
A
HOH
316
3
HOH
HOH
316
A
HOH
317
3
HOH
HOH
317
A
HOH
318
3
HOH
HOH
318
A
HOH
319
3
HOH
HOH
319
A
HOH
320
3
HOH
HOH
320
A
HOH
321
3
HOH
HOH
321
A
HOH
322
3
HOH
HOH
322
A
HOH
323
3
HOH
HOH
323
A
HOH
324
3
HOH
HOH
324
A
HOH
325
3
HOH
HOH
325
A
HOH
326
3
HOH
HOH
326
A
HOH
327
3
HOH
HOH
327
A
HOH
328
3
HOH
HOH
328
A
HOH
329
3
HOH
HOH
329
A
HOH
330
3
HOH
HOH
330
A
HOH
331
3
HOH
HOH
331
A
HOH
332
3
HOH
HOH
332
A
HOH
333
3
HOH
HOH
333
A
HOH
334
3
HOH
HOH
334
A
HOH
335
3
HOH
HOH
335
A
HOH
336
3
HOH
HOH
336
A
HOH
337
3
HOH
HOH
337
A
HOH
338
3
HOH
HOH
338
A
HOH
339
3
HOH
HOH
339
A
HOH
340
3
HOH
HOH
340
A
HOH
341
3
HOH
HOH
341
A
HOH
342
3
HOH
HOH
342
A
HOH
343
3
HOH
HOH
343
A
HOH
344
3
HOH
HOH
344
A
HOH
345
3
HOH
HOH
345
A
HOH
346
3
HOH
HOH
346
A
HOH
347
3
HOH
HOH
347
A
HOH
348
3
HOH
HOH
348
A
HOH
349
3
HOH
HOH
349
A
HOH
350
3
HOH
HOH
350
A
HOH
351
3
HOH
HOH
351
A
HOH
352
3
HOH
HOH
352
A
HOH
353
3
HOH
HOH
353
A
HOH
354
3
HOH
HOH
354
A
HOH
355
3
HOH
HOH
355
A
HOH
356
3
HOH
HOH
356
A
HOH
357
3
HOH
HOH
357
A
n
1
-3
A
n
2
-2
A
n
3
-1
A
ALA
0
n
4
ALA
0
A
VAL
1
n
5
VAL
1
A
ASN
2
n
6
ASN
2
A
ASP
3
n
7
ASP
3
A
GLY
4
n
8
GLY
4
A
ASP
5
n
9
ASP
5
A
MET
6
n
10
MET
6
A
ARG
7
n
11
ARG
7
A
LEU
8
n
12
LEU
8
A
ALA
9
n
13
ALA
9
A
ASP
10
n
14
ASP
10
A
GLY
11
n
15
GLY
11
A
GLY
12
n
16
GLY
12
A
ALA
13
n
17
ALA
13
A
THR
14
n
18
THR
14
A
ASN
15
n
19
ASN
15
A
GLN
16
n
20
GLN
16
A
GLY
17
n
21
GLY
17
A
ARG
18
n
22
ARG
18
A
VAL
19
n
23
VAL
19
A
GLU
20
n
24
GLU
20
A
ILE
21
n
25
ILE
21
A
PHE
22
n
26
PHE
22
A
TYR
23
n
27
TYR
23
A
ARG
24
n
28
ARG
24
A
GLY
25
n
29
GLY
25
A
GLN
26
n
30
GLN
26
A
TRP
27
n
31
TRP
27
A
GLY
28
n
32
GLY
28
A
THR
29
n
33
THR
29
A
VAL
30
n
34
VAL
30
A
CYS
31
n
35
CYS
31
A
ASP
32
n
36
ASP
32
A
ASN
33
n
37
ASN
33
A
LEU
34
n
38
LEU
34
A
TRP
35
n
39
TRP
35
A
ASP
36
n
40
ASP
36
A
LEU
37
n
41
LEU
37
A
THR
38
n
42
THR
38
A
ASP
39
n
43
ASP
39
A
ALA
40
n
44
ALA
40
A
SER
41
n
45
SER
41
A
VAL
42
n
46
VAL
42
A
VAL
43
n
47
VAL
43
A
CYS
44
n
48
CYS
44
A
ARG
45
n
49
ARG
45
A
ALA
46
n
50
ALA
46
A
LEU
47
n
51
LEU
47
A
GLY
48
n
52
GLY
48
A
PHE
49
n
53
PHE
49
A
GLU
50
n
54
GLU
50
A
ASN
51
n
55
ASN
51
A
ALA
52
n
56
ALA
52
A
THR
53
n
57
THR
53
A
GLN
54
n
58
GLN
54
A
ALA
55
n
59
ALA
55
A
LEU
56
n
60
LEU
56
A
GLY
57
n
61
GLY
57
A
ARG
58
n
62
ARG
58
A
ALA
59
n
63
ALA
59
A
ALA
60
n
64
ALA
60
A
PHE
61
n
65
PHE
61
A
GLY
62
n
66
GLY
62
A
GLN
63
n
67
GLN
63
A
GLY
64
n
68
GLY
64
A
SER
65
n
69
SER
65
A
GLY
66
n
70
GLY
66
A
PRO
67
n
71
PRO
67
A
ILE
68
n
72
ILE
68
A
MET
69
n
73
MET
69
A
LEU
70
n
74
LEU
70
A
ASP
71
n
75
ASP
71
A
GLU
72
n
76
GLU
72
A
VAL
73
n
77
VAL
73
A
GLN
74
n
78
GLN
74
A
CYS
75
n
79
CYS
75
A
THR
76
n
80
THR
76
A
GLY
77
n
81
GLY
77
A
THR
78
n
82
THR
78
A
GLU
79
n
83
GLU
79
A
ALA
80
n
84
ALA
80
A
SER
81
n
85
SER
81
A
LEU
82
n
86
LEU
82
A
ALA
83
n
87
ALA
83
A
ASP
84
n
88
ASP
84
A
CYS
85
n
89
CYS
85
A
LYS
86
n
90
LYS
86
A
SER
87
n
91
SER
87
A
LEU
88
n
92
LEU
88
A
GLY
89
n
93
GLY
89
A
TRP
90
n
94
TRP
90
A
LEU
91
n
95
LEU
91
A
LYS
92
n
96
LYS
92
A
SER
93
n
97
SER
93
A
ASN
94
n
98
ASN
94
A
CYS
95
n
99
CYS
95
A
ARG
96
n
100
ARG
96
A
HIS
97
n
101
HIS
97
A
GLU
98
n
102
GLU
98
A
ARG
99
n
103
ARG
99
A
ASP
100
n
104
ASP
100
A
ALA
101
n
105
ALA
101
A
GLY
102
n
106
GLY
102
A
VAL
103
n
107
VAL
103
A
VAL
104
n
108
VAL
104
A
CYS
105
n
109
CYS
105
A
THR
106
n
110
THR
106
A
ASN
107
n
111
ASN
107
A
GLU
108
n
112
GLU
108
A
THR
109
n
113
THR
109
A
n
114
110
A
n
115
111
A
n
116
112
A
n
117
113
A
THR
114
n
118
THR
114
A
LEU
115
n
119
LEU
115
A
author_defined_assembly
1
monomeric
A
ASN
51
GLYCOSYLATION SITE
A
ASN
55
ASN
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
O
ARG
7
A
O
ARG
11
A
N
GLU
20
A
N
GLU
24
A
O
GLY
17
A
O
GLY
21
A
N
VAL
103
A
N
VAL
107
A
O
GLY
102
A
O
GLY
106
A
N
LEU
56
A
N
LEU
60
A
O
ILE
21
A
O
ILE
25
A
N
GLY
28
A
N
GLY
32
1
A
ALA
-3
A
ALA
1
1
Y
1
A
PRO
-2
A
PRO
2
1
Y
1
A
LEU
-1
A
LEU
3
1
Y
1
A
ARG
110
A
ARG
114
1
Y
1
A
SER
111
A
SER
115
1
Y
1
A
THR
112
A
THR
116
1
Y
1
A
HIS
113
A
HIS
117
1
Y
PARHCSDX.PRO
PARAM11.WAT
PARAM3_MOD.CHO
20
0.218
0.186
0.186
2.00
8.00
934
9649
10
99.6
RANDOM
100000
0
1
INDIVIDUAL RESTRAINED, RMS BONDS 3.5 A**2
FREE R-FACTOR
0
MIRAS
6.0
0.18
2.00
8.00
57
903
14
0
832
0.008
1.5
1.0
2.0
2.0
4.0
0.277
0.27
2.09
114
1056
8
10
100.0
15
2.00
20.0
1BY2
9843
0
0.069
1
7.3
6.2
99.6
0.186
2.00
2.11
3.7
1
6.0
100.0
data reduction
MOSFLM
data scaling
SCALA
(CCP4)
model building
CCP4
refinement
X-PLOR
3.84
data scaling
CCP4
(SCALA)
phasing
CCP4
MAC-2 BINDING PROTEIN
STRUCTURE OF M2BP SCAVENGER RECEPTOR CYSTEINE-RICH DOMAIN
1
N
N
2
N
N
3
N
N
A
LEU
37
A
LEU
41
HELX_P
A
ALA
46
A
ALA
50
1
1
10
A
LEU
82
A
LEU
86
HELX_P
A
ASP
84
A
ASP
88
5
2
3
A
HIS
97
A
HIS
101
HELX_P
A
ARG
99
A
ARG
103
5
3
3
disulf
2.021
A
CYS
31
A
SG
CYS
35
1_555
A
CYS
95
A
SG
CYS
99
1_555
disulf
2.026
A
CYS
44
A
SG
CYS
48
1_555
A
CYS
105
A
SG
CYS
109
1_555
disulf
2.024
A
CYS
75
A
SG
CYS
79
1_555
A
CYS
85
A
SG
CYS
89
1_555
covale
1.444
one
N-Glycosylation
A
ASN
51
A
ND2
ASN
55
1_555
A
NAG
201
B
C1
NAG
1_555
EXTRACELLULAR MODULE
EXTRACELLULAR MODULE, SCAVENGER RECEPTOR, TUMOUR-ASSOCIATED ANTIGEN, EXTRACELLULAR MATRIX, GLYCOSYLATED PROTEIN
LG3BP_HUMAN
UNP
1
1
Q08380
MTPPRLFWVWLLVAGTQGVNDGDMRLADGGATNQGRVEIFYRGQWGTVCDNLWDLTDASVVCRALGFENATQALGRAAFG
QGSGPIMLDEVQCTGTEASLADCKSLGWLKSNCRHERDAGVVCTNETRSTHTLDLSRELSEALGQIFDSQRGCDLSISVN
VQGEDALGFCGHTVILTANLEAQALWKEPGSNVTMSVDAECVPMVRDLLRYFYSRRIDITLSSVKCFHKLASAYGARQLQ
GYCASLFAILLPQDPSFQMPLDLYAYAVATGDALLEKLCLQFLAWNFEALTQAEAWPSVPTDLLQLLLPRSDLAVPSELA
LLKAVDTWSWGERASHEEVEGLVEKIRFPMMLPEELFELQFNLSLYWSHEALFQKKTLQALEFHTVPFQLLARYKGLNLT
EDTYKPRIYTSPTWSAFVTDSSWSARKSQLVYQSRRGPLVKYSSDYFQAPSDYRYYPYQSFQTPQHPSFLFQDKRVSWSL
VYLPTIQSCWNYGFSCSSDELPVLGLTKSGGSDRTIAYENKALMLCEGLFVADVTDFEGWKAAIPSALDTNSSKSTSSFP
CPAGHFNGFRTVIRPFYLTNSSGVD
19
133
1BY2
1
115
Q08380
A
1
5
119
4
2
anti-parallel
anti-parallel
anti-parallel
anti-parallel
A
MET
6
A
MET
10
A
ALA
9
A
ALA
13
A
GLN
16
A
GLN
20
A
ILE
21
A
ILE
25
A
GLY
102
A
GLY
106
A
CYS
105
A
CYS
109
A
ALA
52
A
ALA
56
A
LEU
56
A
LEU
60
A
GLU
20
A
GLU
24
A
TYR
23
A
TYR
27
A
GLN
26
A
GLN
30
A
THR
29
A
THR
33
96
P 43 21 2